Filing Details
- Accession Number:
- 0001209191-23-058458
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-13 13:40:19
- Reporting Period:
- 2023-12-12
- Accepted Time:
- 2023-12-13 13:40:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1641281 | Bolt Biotherapeutics Inc. | BOLT | Pharmaceutical Preparations (2834) | 472804636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1724190 | P. William Quinn | C/O Bolt Biotherapeutics, Inc. 900 Chesapeake Drive Redwood City CA 94063 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-06 | 1,829 | $1.18 | 26,272 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-12-06 | 2,500 | $0.78 | 28,772 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-12-12 | 7,500 | $0.95 | 36,272 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Shares acquired under the issuer's Employee Stock Purchase Plan.